Omar K Sial1, Brandon L Warren2, Lyonna F Alcantara1, Eric M Parise1, Carlos A Bolaños-Guzmán3. 1. Department of Psychology and Program in Neuroscience, Florida State University, Tallahassee, FL 32306-4301, United States. 2. National Institute on Drug Abuse, Behavioral Neuroscience Research Branch, Baltimore, MD, United States. 3. Department of Psychology and Program in Neuroscience, Florida State University, Tallahassee, FL 32306-4301, United States. Electronic address: bolanos@psy.fsu.edu.
Abstract
BACKGROUND: Animal models capable of differentiating the neurobiological intricacies between physical and emotional stress are scarce. Current models rely primarily on physical stressors (e.g., chronic unpredictable or mild stress, social defeat, learned helplessness), and neglect the impact of psychological stress alone. This is surprising given extensive evidence that a traumatic event needs not be directly experienced to produce enduring perturbations on an individual's health and psychological well-being. Post-traumatic stress disorder (PTSD), a highly debilitating neuropsychiatric disorder characterized by intense fear of trauma-related stimuli, often occurs in individuals that have only witnessed a traumatic event. NEW METHOD: By modifying the chronic social defeat stress (CSDS) paradigm to include a witness component (witnessing the social defeat of another mouse), we demonstrate a novel behavioral paradigm capable of inducing a robust behavioral syndrome reminiscent of PTSD in emotionally stressed adult mice. RESULTS: We describe the vicarious social defeat stress (VSDS) model that is capable of inducing a host of behavioral deficits that include social avoidance and other depressive- and anxiety-like phenotypes in adult male mice. VSDS exposure induces weight loss and spike in serum corticosterone (CORT) levels. A month after stress, these mice retain the social avoidant phenotype and have an increased CORT response when exposed to subsequent stress. COMPARISON WITH EXISTING METHOD(S): The VSDS is a novel paradigm capable of inducing emotional stress by isolating physical stress/confrontation in mice. CONCLUSIONS: The VSDS model can be used to study the short- and long-term neurobiological consequences of exposure to emotional stress in mice.
BACKGROUND: Animal models capable of differentiating the neurobiological intricacies between physical and emotional stress are scarce. Current models rely primarily on physical stressors (e.g., chronic unpredictable or mild stress, social defeat, learned helplessness), and neglect the impact of psychological stress alone. This is surprising given extensive evidence that a traumatic event needs not be directly experienced to produce enduring perturbations on an individual's health and psychological well-being. Post-traumatic stress disorder (PTSD), a highly debilitating neuropsychiatric disorder characterized by intense fear of trauma-related stimuli, often occurs in individuals that have only witnessed a traumatic event. NEW METHOD: By modifying the chronic social defeat stress (CSDS) paradigm to include a witness component (witnessing the social defeat of another mouse), we demonstrate a novel behavioral paradigm capable of inducing a robust behavioral syndrome reminiscent of PTSD in emotionally stressed adult mice. RESULTS: We describe the vicarious social defeat stress (VSDS) model that is capable of inducing a host of behavioral deficits that include social avoidance and other depressive- and anxiety-like phenotypes in adult male mice. VSDS exposure induces weight loss and spike in serum corticosterone (CORT) levels. A month after stress, these mice retain the social avoidant phenotype and have an increased CORT response when exposed to subsequent stress. COMPARISON WITH EXISTING METHOD(S): The VSDS is a novel paradigm capable of inducing emotional stress by isolating physical stress/confrontation in mice. CONCLUSIONS: The VSDS model can be used to study the short- and long-term neurobiological consequences of exposure to emotional stress in mice.
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: Olivier Berton; Colleen A McClung; Ralph J Dileone; Vaishnav Krishnan; William Renthal; Scott J Russo; Danielle Graham; Nadia M Tsankova; Carlos A Bolanos; Maribel Rios; Lisa M Monteggia; David W Self; Eric J Nestler Journal: Science Date: 2006-02-10 Impact factor: 47.728
Authors: Brandon L Warren; Vincent F Vialou; Sergio D Iñiguez; Lyonna F Alcantara; Katherine N Wright; Jiang Feng; Pamela J Kennedy; Quincey Laplant; Li Shen; Eric J Nestler; Carlos A Bolaños-Guzmán Journal: Biol Psychiatry Date: 2012-07-12 Impact factor: 13.382
Authors: Julie E Finnell; Brandon L Muniz; Akhila R Padi; Calliandra M Lombard; Casey M Moffitt; Christopher S Wood; L Britt Wilson; Lawrence P Reagan; Marlene A Wilson; Susan K Wood Journal: Biol Psychiatry Date: 2018-01-31 Impact factor: 13.382
Authors: Sergio D Iñiguez; Francisco J Flores-Ramirez; Lace M Riggs; Jason B Alipio; Israel Garcia-Carachure; Mirella A Hernandez; David O Sanchez; Mary Kay Lobo; Peter A Serrano; Stephen H Braren; Samuel A Castillo Journal: Biol Psychiatry Date: 2017-07-29 Impact factor: 13.382
Authors: Elizabeth S Williams; Claire E Manning; Andrew L Eagle; Ashlyn Swift-Gallant; Natalia Duque-Wilckens; Sadhana Chinnusamy; Adam Moeser; Cynthia Jordan; Gina Leinninger; Alfred Jay Robison Journal: Biol Psychiatry Date: 2019-08-22 Impact factor: 13.382
Authors: Christine N Yohn; Andrew Dieterich; Allyson S Bazer; Isabella Maita; Megan Giedraitis; Benjamin Adam Samuels Journal: Neuropsychopharmacology Date: 2019-09-07 Impact factor: 7.853